Noticias Imprimir 2022Mayo Clinic research shows bebtelovimab to be a reliable option for treating COVID-19 in era of BA.2, other subvariants Aug. 15, 2022, 02:09 p.m. CDT2021Post-COVID symptoms: Women differ distinctly from men Dec. 02, 2021, 05:22 p.m. CDT PST-20308858 Inicio Noticias